XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.2
Earnings per common share
6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
Earnings per common share

8. Earnings per common share

The computations of basic earnings per common share follow:

 

 

Three Months Ended June 30

 

 

Six Months Ended June 30

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

 

 

(In thousands, except per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income available to common shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

473,260

 

 

 

493,160

 

 

 

956,002

 

 

 

845,770

 

Less: Preferred stock dividends (a)

 

 

(18,130

)

 

 

(18,130

)

 

 

(36,260

)

 

 

(36,260

)

Net income available to common equity

 

 

455,130

 

 

 

475,030

 

 

 

919,742

 

 

 

809,510

 

Less: Income attributable to unvested stock-based

   compensation awards

 

 

(2,498

)

 

 

(2,432

)

 

 

(5,024

)

 

 

(4,172

)

Net income available to common shareholders

 

$

452,632

 

 

 

472,598

 

 

 

914,718

 

 

 

805,338

 

Weighted-average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common shares outstanding (including common stock

   issuable) and unvested stock-based compensation awards

 

 

136,182

 

 

 

145,571

 

 

 

137,403

 

 

 

147,510

 

Less: Unvested stock-based compensation awards

 

 

(749

)

 

 

(746

)

 

 

(749

)

 

 

(764

)

Weighted-average shares outstanding

 

 

135,433

 

 

 

144,825

 

 

 

136,654

 

 

 

146,746

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per common share

 

$

3.34

 

 

 

3.26

 

 

 

6.69

 

 

 

5.49

 

 

 (a)Including impact of not as yet declared cumulative dividends.

The computations of diluted earnings per common share follow:

 

 

Three Months Ended June 30

 

 

Six Months Ended June 30

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

 

 

(In thousands, except per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income available to common equity

 

$

455,130

 

 

 

475,030

 

 

 

919,742

 

 

 

809,510

 

Less: Income attributable to unvested stock-based

   compensation awards

 

 

(2,497

)

 

 

(2,430

)

 

 

(5,023

)

 

 

(4,168

)

Net income available to common shareholders

 

$

452,633

 

 

 

472,600

 

 

 

914,719

 

 

 

805,342

 

Adjusted weighted-average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common and unvested stock-based compensation awards

 

 

136,182

 

 

 

145,571

 

 

 

137,403

 

 

 

147,510

 

Less: Unvested stock-based compensation awards

 

 

(749

)

 

 

(746

)

 

 

(749

)

 

 

(764

)

Plus: Incremental shares from assumed conversion of

   stock-based compensation awards and warrants to

   purchase common stock

 

 

31

 

 

 

173

 

 

 

31

 

 

 

195

 

Adjusted weighted-average shares outstanding

 

 

135,464

 

 

 

144,998

 

 

 

136,685

 

 

 

146,941

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per common share

 

$

3.34

 

 

 

3.26

 

 

 

6.69

 

 

 

5.48

 

GAAP defines unvested share-based awards that contain nonforfeitable rights to dividends or dividend equivalents (whether paid or unpaid) as participating securities that shall be included in the computation of earnings per common share pursuant to the two-class method.  The Company has issued stock-based compensation awards in the form of restricted stock and restricted stock units which, in accordance with GAAP, are considered participating securities.

Stock-based compensation awards and warrants to purchase common stock of M&T representing 115,293 and 212,244 common shares during the three-month periods ended June 30, 2019 and 2018, respectively, and 197,598 and 224,844 common shares during the six-month periods ended June 30, 2019 and 2018, respectively, were not included in the computations of diluted earnings per common share because the effect on those periods would have been antidilutive.